Transaction DateRecipientSharesTypePriceValue
13th November 2020William M. Haskel6,892Open or private sale$5.93$40,869.56
13th November 2020Evan Loh20,928Open or private sale$5.93$124,103.04
13th November 2020Adam Woodrow15,000Open or private sale$5.93$88,950.00
13th November 2020Randall B. Brenner8,357Open or private sale$5.93$49,557.01
12th November 2020Adam Woodrow37,500Grant/award etc.$0.00
12th November 2020Evan Loh75,000Grant/award etc.$0.00
12th November 2020Randall B. Brenner21,250Grant/award etc.$0.00
12th November 2020William M. Haskel23,125Grant/award etc.$0.00
10th November 2020Jeffrey Stein50,000Open or private purchase$2.00$100,015.00
29th October 2020Evan Loh39,479Exercise of derivative$4.30$169,759.70
Transcept Pharmaceuticals
Transcept Pharmaceuticals logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.



Ticker: TSPT
Sector: Unknown
Industry: Unknown
SEC Central Index Key (CIK): 1178711
Employees:
Exchange: None
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $142 M (0%)
Inventory, Net: $18 M (0%)
Assets, Current: $222 M (-8%)
Property, Plant and Equipment, Net: $976 Th (0%)
Other Assets, Noncurrent: $148 Th (0%)
Assets: $227 M (-9%)
Accounts Payable, Current: $6 M (35%)
Accrued Liabilities, Current: $15 M (-10%)
Liabilities, Current: $34 M (40%)
Long-term Debt, Excluding Current Maturities: $252 M (-3%)
Other Liabilities, Noncurrent: $3 M (-5%)
Liabilities: $291 M (0%)
Common Stock, Value, Issued: $45 Th (12%)
Common Stock, Shares, Issued: $45 M (13%)
Additional Paid in Capital, Common Stock: $698 M (3%)
Retained Earnings (Accumulated Deficit): $762 M (0%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $254 Th (243%)
Stockholders' Equity (Parent): $63 M (0%)
Liabilities and Equity: $227 M (-9%)
Revenue: $9 M (-45%)
Operating Income/Loss: $18 M (-56%)